Literature DB >> 27151940

Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats.

John H Winston1, Sushil K Sarna2.   

Abstract

Gastric hypersensitivity (GHS) and anxiety are prevalent in functional dyspepsia patients; their underlying mechanisms remain unknown largely because of lack of availability of live visceral tissues from human subjects. Recently, we demonstrated in a preclinical model that rats subjected to neonatal colon inflammation show increased basal plasma norepinephrine (NE), which contributes to GHS through the upregulation of nerve growth factor (NGF) expression in the gastric fundus. We tested the hypothesis that neonatal colon inflammation increases anxiety-like behavior and sympathetic nervous system activity, which upregulates the expression of NGF to induce GHS in adult life. Chemical sympathectomy, but not adrenalectomy, suppressed the elevated NGF expression in the fundus muscularis externa and GHS. The measurement of heart rate variability showed a significant increase in the low frequency-to-high frequency ratio in GHS vs. the control rats. Stimulus-evoked release of NE from the fundus muscularis externa strips was significantly greater in GHS than in the control rats. Tyrosine hydroxylase expression was increased in the celiac ganglia of the GHS vs. the control rats. We found an increase in trait but not stress-induced anxiety-like behavior in GHS rats in an elevated plus maze. We concluded that neonatal programming triggered by colon inflammation upregulates tyrosine hydroxylase in the celiac ganglia, which upregulates the release of NE in the gastric fundus muscularis externa. The increase of NE release from the sympathetic nerve terminals concentration dependently upregulates NGF, which proportionately increases the visceromotor response to gastric distention. Neonatal programming concurrently increases anxiety-like behavior in GHS rats.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  functional dyspepsia; nerve growth factor; norepinephrine; visceral hypersensitivity

Mesh:

Substances:

Year:  2016        PMID: 27151940      PMCID: PMC4967178          DOI: 10.1152/ajpgi.00067.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  51 in total

Review 1.  alpha2-Adrenoceptor agonists: shedding light on neuroprotection?

Authors:  Daqing Ma; Nishanthan Rajakumaraswamy; Mervyn Maze
Journal:  Br Med Bull       Date:  2005-01-31       Impact factor: 4.291

Review 2.  Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.

Authors:  John M Rosen; Jose T Cocjin; Jennifer V Schurman; Jennifer M Colombo; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

3.  Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion.

Authors:  M Vallée; W Mayo; F Dellu; M Le Moal; H Simon; S Maccari
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

4.  Effect of mental stress and cisapride on autonomic nerve functions in functional dyspepsia.

Authors:  K Hveem; S Svebak; T Hausken; A Berstad
Journal:  Scand J Gastroenterol       Date:  1998-02       Impact factor: 2.423

Review 5.  Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death.

Authors:  P S Chen; L S Chen; J M Cao; B Sharifi; H S Karagueuzian; M C Fishbein
Journal:  Cardiovasc Res       Date:  2001-05       Impact factor: 10.787

6.  Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

Authors:  J R Goodhand; M Wahed; J E Mawdsley; A D Farmer; Q Aziz; D S Rampton
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

7.  Post-infectious functional gastrointestinal disorders in children.

Authors:  Miguel Saps; Licia Pensabene; Lucio Di Martino; Annamaria Staiano; Joshua Wechsler; Xiaotian Zheng; Carlo Di Lorenzo
Journal:  J Pediatr       Date:  2008-02-14       Impact factor: 4.406

8.  Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress.

Authors:  John H Winston; Guang-Yin Xu; Sushil K Sarna
Journal:  Gastroenterology       Date:  2009-10-01       Impact factor: 22.682

9.  Transient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression- and anxiety-like behavior as adults.

Authors:  Liansheng Liu; Qian Li; Robert Sapolsky; Min Liao; Kshama Mehta; Aditi Bhargava; Pankaj J Pasricha
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

Review 10.  The role of psychosocial factors and psychiatric disorders in functional dyspepsia.

Authors:  Lukas Van Oudenhove; Qasim Aziz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

View more
  12 in total

Review 1.  Early-life adversity, epigenetics, and visceral hypersensitivity.

Authors:  S Liu; S I Hagiwara; A Bhargava
Journal:  Neurogastroenterol Motil       Date:  2017-09       Impact factor: 3.598

2.  Altered enteric expression of the homeobox transcription factor Phox2b in patients with diverticular disease.

Authors:  François Cossais; Christina Lange; Martina Barrenschee; Marie Möding; Michael Ebsen; Ilka Vogel; Martina Böttner; Thilo Wedel
Journal:  United European Gastroenterol J       Date:  2019-01-16       Impact factor: 4.623

3.  Upregulation of gastric norepinephrine with beta-adrenoceptors and gastric dysmotility in a rat model of functional dyspepsia.

Authors:  J Song; T Wang; X Zhang; B Li; C Zhu; S Zhang
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

Review 4.  Choosing an Animal Model for the Study of Functional Dyspepsia.

Authors:  Yang Ye; Xue-Rui Wang; Yang Zheng; Jing-Wen Yang; Na-Na Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-12

5.  Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia.

Authors:  Shin-Ichiro Hagiwara; Esha Kaushal; Sreenivasan Paruthiyil; Pankaj J Pasricha; Burcu Hasdemir; Aditi Bhargava
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A.

Authors:  Sheng-Nan Huang; Jinbao Wei; Lan-Ting Huang; Pei-Jun Ju; Jinghong Chen; Yong-Xiang Wang
Journal:  Neural Plast       Date:  2020-05-23       Impact factor: 3.599

7.  Effect and mechanisms of sacral nerve stimulation on visceral hypersensitivity mediated by nerve growth factor.

Authors:  Liuqin Jiang; Bixing Ye; Yun Wang; Ting Yu; Hairong Xu
Journal:  J Cell Mol Med       Date:  2019-10-22       Impact factor: 5.310

8.  Chaihulonggumulitang Shows Psycho-cardiology Therapeutic Effects on Acute Myocardial Infarction by Enhancing Bone Marrow Mesenchymal Stem Cells Mobilization.

Authors:  Chao Wang; Hongsen Du; Jiqiu Hou; Shasha Yan; Jingjing Yang; Yun Wang; Xiujing Zhang; Lili Zhu; Haibin Zhao
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

9.  Bulleyaconitine A Exerts Antianxiety and Antivisceral Hypersensitivity Effects.

Authors:  Sheng-Nan Huang; BeiBei Yang; Le Ma; Lan-Ting Huang; Pei-Jun Ju; Jinbao Wei; Usman Ali; Yong-Xiang Wang; Jinghong Chen
Journal:  Front Pharmacol       Date:  2020-03-19       Impact factor: 5.810

10.  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.

Authors:  Jannis Kountouras; Emmanuel Gavalas; Apostolis Papaefthymiou; Ioannis Tsechelidis; Stergios A Polyzos; Serhat Bor; Mircea Diculescu; Κhaled Jadallah; Mazurek Tadeusz; Tarkan Karakan; Αnna Bochenek; Jerzy Rozciecha; Piotr Dabrowski; Zeno Sparchez; Orhan Sezgin; Macit Gülten; Niazy Abu Farsakh; Michael Doulberis
Journal:  Medicina (Kaunas)       Date:  2020-07-08       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.